The consortium of the new project: TRANSCAN-3 Sustained collaboration of national and regional programmes in cancer research, funded by the European Commission under Horizon 2020 from 2021 to 2026 (Grant Agreement no. 964264), has launched its first Joint Transnational Call co-funded by the European Commission (JTC 2021) on the topic: “Next generation cancer immunotherapy: targeting the tumour microenvironment”.
28 funding organizations from 19 countries are participating.
The submission deadline for pre-proposals is on 29thof June 2021.
It is expected that consortia invited for the full-proposal stage will be asked to submit their proposal on November 2021.